Yaming Wei
Impact in
-
- Mesenchymal stem cell research
- Inflammatory Bowel Disease
-
- MicroRNA in disease regulation
Papers in
-
- Hematopoietic Stem Cell Transplantation 5
- Blood groups and transfusion 2
- Platelet Disorders and Treatments 2
- Genetics 4
- Mesenchymal stem cell research 4
- Co-authors
- Zhaohu Yuan (12 shared papers)Rongliang Zheng (5 shared papers)Xiaojie Chen (5 shared papers)Yanfen Xing (3 shared papers)Fangxin Zhang (1 shared paper)Zhong‐Jian Jia (2 shared papers)Huabao Xiong (2 shared papers)Xin Xu (2 shared papers)
- Journals
- Stem Cell Research & Therapy (3 papers)International Journal of Oncology (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Frontiers in Oncology (1 paper)Cancer Cell International (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yaming Wei
33 papers receiving 398 citations
Peers
Comparison fields: 5 of 60
- Genetics 45
- Cancer Research 34
- Oncology 56
- Pathology and Forensic Medicine 39
- Nutrition and Dietetics 27
Countries citing papers authored by Yaming Wei
This map shows the geographic impact of Yaming Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaming Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaming Wei more than expected).
Fields of papers citing papers by Yaming Wei
This network shows the impact of papers produced by Yaming Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaming Wei. The network helps show where Yaming Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaming Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 46 | |
| 2 | 2001 | 43 | |
| 3 | 2009 | 33 | |
| 4 | 2015 | 33 | |
| 5 | 2018 | 33 | |
| 6 | 2015 | 29 | |
| 7 | 2017 | 27 | |
| 8 | 2018 | 26 | |
| 9 | 2018 | 14 | |
| 10 | 2020 | 14 | |
| 11 | 2016 | 13 | |
| 12 | Effects of diethyldithiocarbamate on proliferation, redifferention, and apoptosis in human hepatoma cells. | 2001 | 12 |
| 13 | 2018 | 10 | |
| 14 | Combined induction with anti-PD-1 and anti-CTLA-4 antibodies provides synergistic antitumor effects in DC-CIK cells in renal carcinoma cell lines. | 2019 | 10 |
| 15 | 2020 | 8 | |
| 16 | Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines. | 2001 | 7 |
| 17 | 2004 | 7 | |
| 18 | 2008 | 6 | |
| 19 | 2020 | 5 | |
| 20 | In vitro effects on proliferation, telomerase activity and apoptosis of an eremophilanoid sesquiterpene from Senecio oldhamianus maxim in cultured human tumor cell lines. | 2004 | 4 |
About Yaming Wei
Yaming Wei is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Biochemistry, having authored 36 papers that have together received 411 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (5 papers), Mesenchymal stem cell research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (3 papers), Blood transfusion and management (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Blood groups and transfusion (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Genetics (45 citations), Cancer Research (34 citations), Oncology (56 citations), Pathology and Forensic Medicine (39 citations) and Nutrition and Dietetics (27 citations). Yaming Wei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhaohu Yuan, Rongliang Zheng, Xiaojie Chen, Yanfen Xing, Fangxin Zhang, Zhong‐Jian Jia, Huabao Xiong, Xin Xu, 聂玉强 and Yuyuan Li. Their work appears in journals such as Stem Cell Research & Therapy, International Journal of Oncology, International Journal of Radiation Oncology*Biology*Physics, Frontiers in Oncology and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.